🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was an open-label, multicenter, single-arm, Phase II trial of bevacizu...
Status
Completed
Location
Multiple Locations
Start Date
2006-03
Trial ID
NCT00312728
Treatments Being Tested
This is a Multi-center, Open-label, Randomized Controlled,phase 2 clinical ...
Status
Terminated
Location
Tongji hospital of Tongji Medical College, Huazhong University of Science and Technology
Start Date
2020-04-03
Trial ID
NCT04294784
Treatments Being Tested
Guidelines recommend FOLFIRI in combination with bevacizumab or cetuximab a...
Status
Recruiting
Location
The second affiliated hospital, Zhejiang University School of Medicine
Start Date
2024-11-12
Trial ID
NCT06540326
Treatments Being Tested
This study is a Phase II, multi-site, randomized, open-label clinical study...
Status
Active Not Recruiting
Location
Beverly Hills Cancer Center
Start Date
2024-08-26
Trial ID
NCT06449222
MSI-H is a biomarker for solid tumors benefiting from immunotherapy. Recent...
Status
Unknown
Location
Tianjin Medical University Cancer Institute & Hospital
Start Date
2019-01-01
Trial ID
NCT05035381
Treatments Being Tested
The study aims to evaluate the efficacy and safety of the QL1706 combinatio...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-07-25
Trial ID
NCT07045805
Treatments Being Tested
Given that pyrotinib has been proven to exert significant efficacy against ...
Status
Recruiting
Location
Peking University People's Hospital
Start Date
2026-07-06
Trial ID
NCT07600164
Treatments Being Tested
This is a Phase 1, open-label, dose-escalation, and dose-expansion, with a ...
Status
Active Not Recruiting
Location
Research Site
Start Date
2019-11-06
Trial ID
NCT04104672
Treatments Being Tested
This is a modular, phase I/ phase 1 b, open-label, multicentre study of cer...
Status
Active Not Recruiting
Location
Research Site
Start Date
2014-10-31
Trial ID
NCT02264678
Treatments Being Tested
The main goals of this study are to learn about the safety of sacituzumab t...
Status
Recruiting
Location
University of Alabama at Birmingham ( Site 0006)
Start Date
2025-04-09
Trial ID
NCT06824467